| |
| |
|
| Insider
Information: |
Monia Brett P |
| Relationship: |
Director |
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
180,289 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,548,038 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
180,289 |
|
|
| Total
Value |
$6,548,038 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
9
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
7
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -146.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ionis Pharmaceuticals Inc |
IONS |
CEO Level 15, Director |
2024-02-29 |
174,289 |
2012-01-01 |
0 |
Premium* |
|
|
Cognition Therapeutics Inc |
CGTX |
Director |
2023-06-09 |
6,000 |
2023-06-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
116 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2014-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,151 |
2,018 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2016-01-19 |
4 |
S |
$41.46 |
$91,541 |
D/D |
(2,208) |
7,693 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2024-01-25 |
4 |
S |
$51.75 |
$118,249 |
D/D |
(2,285) |
151,851 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-04-19 |
4 |
OE |
$11.12 |
$27,800 |
D/D |
2,500 |
8,195 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-04-19 |
4 |
AS |
$21.25 |
$53,125 |
D/D |
(2,500) |
5,695 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-01-17 |
4 |
S |
$46.29 |
$115,819 |
D/D |
(2,502) |
11,772 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2021-01-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,634 |
51,409 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO |
• – – |
2018-01-16 |
4 |
S |
$51.76 |
$146,015 |
D/D |
(2,821) |
15,783 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-08-26 |
4 |
AS |
$25.58 |
$74,403 |
D/D |
(2,909) |
769 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Operating Officer |
• – – |
2019-01-15 |
4 |
D |
$58.26 |
$208,105 |
D/D |
(3,572) |
22,275 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-10-12 |
4 |
AS |
$46.00 |
$173,420 |
D/D |
(3,770) |
118,111 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,025 |
5,140 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-05-22 |
4 |
AS |
$40.13 |
$197,907 |
D/D |
(4,931) |
140,374 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2016-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,543 |
8,297 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO & SVP, Translational Med |
• • – |
2019-11-20 |
4 |
AS |
$60.01 |
$346,618 |
D/D |
(5,776) |
16,458 |
0 |
- |
|
| CGTX |
Cognition Therapeutics In... |
Director |
– • – |
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2017-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,402 |
12,395 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-20 |
4 |
S |
$49.64 |
$322,643 |
D/D |
(6,500) |
118,111 |
0 |
% |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2023-12-20 |
4 |
OE |
$47.34 |
$307,710 |
D/D |
6,500 |
124,611 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
COO |
• – – |
2018-01-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,985 |
18,604 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2020-01-15 |
4 |
D |
$62.06 |
$469,360 |
D/D |
(7,563) |
28,643 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-06-08 |
4 |
AS |
$66.22 |
$503,280 |
D/D |
(7,600) |
4,426 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2015-06-08 |
4 |
OE |
$10.29 |
$78,204 |
D/D |
7,600 |
12,026 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
Chief Executive Officer |
• • – |
2022-01-26 |
4 |
D |
$31.44 |
$252,526 |
D/D |
(8,032) |
88,396 |
0 |
- |
|
| IONS |
Ionis Pharmaceuticals Inc |
SVP, Antisense Drug Discovery |
• – – |
2013-06-11 |
4 |
OE |
$15.75 |
$147,656 |
D/D |
9,375 |
15,070 |
0 |
- |
|
116 Records found
|
|
Page 3 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
